CEP-1 inhibitors, also known as p53 inhibitors, belong to a class of chemical compounds designed to modulate the activity of the CEP-1 protein, which is the nematode Caenorhabditis elegans homolog of the tumor suppressor p53 in humans. The CEP-1 protein plays a crucial role in regulating cell cycle progression and apoptosis in C. elegans, and it shares structural and functional similarities with the human p53 protein. These inhibitors are primarily utilized in research settings to gain insights into the fundamental mechanisms of cellular responses to stress and DNA damage. They serve as valuable tools for studying the conserved pathways of cell cycle regulation and programmed cell death across species.
CEP-1 inhibitors are small organic molecules designed to interact with specific components of the CEP-1/p53 pathway. Some of these inhibitors work by disrupting the interaction between CEP-1/p53 and its negative regulator, which is analogous to MDM2 in humans. By blocking this interaction, these inhibitors promote the stabilization and activation of CEP-1/p53, leading to the transcriptional activation of target genes involved in cell cycle arrest and apoptosis. Other CEP-1 inhibitors may directly affect the DNA-binding ability of CEP-1/p53, thereby modulating its transcriptional activity. These compounds allow researchers to manipulate CEP-1/p53 function, dissect its downstream signaling pathways, and unravel the molecular mechanisms governing cellular responses to stressors, ultimately contributing to our understanding of fundamental cellular biology and the evolutionarily conserved roles of p53-like proteins in different organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Nutlin-3 binds to MDM2, preventing its interaction with p53 and promoting p53 stabilization and activation, leading to cell cycle arrest and apoptosis. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $110.00 $268.00 $1533.00 $5103.00 | 9 | |
RITA disrupts the interaction between p53 and MDM2, facilitating p53 activation, which induces cell cycle arrest and apoptosis in cancer cells. | ||||||
PRIMA-1 | 5608-24-2 | sc-200927 sc-200927A | 5 mg 25 mg | $102.00 $408.00 | 1 | |
PRIMA-1 reactivates mutant p53 by converting it to a transcriptionally active conformation, leading to the induction of cell death in cancer cells with mutant p53. | ||||||
Tenovin-6 | 1011557-82-6 | sc-224296 sc-224296A | 1 mg 5 mg | $272.00 $1214.00 | 9 | |
Tenovin-6, like Tenovin-1, inhibits SIRT1 and SIRT2, resulting in p53 activation and apoptosis induction in cancer cells. | ||||||
Amifostine Thiol Dihydrochloride | 14653-77-1 | sc-210796 sc-210796A sc-210796B sc-210796C sc-210796D sc-210796E | 10 mg 50 mg 100 mg 500 mg 1 g 5 g | $140.00 $583.00 $1100.00 $5000.00 $8500.00 $24000.00 | ||
WR-1065 is a radioprotective agent that can inhibit p53 activation by reducing DNA damage, ultimately preventing p53-mediated cell cycle arrest and apoptosis. | ||||||
PhiKan-083 Hydrochloride | 880813-36-5 | sc-479264 | 10 mg | $320.00 | ||
PhiKan083 is a small molecule inhibitor that targets p53 and disrupts its interaction with MDM2, leading to p53 activation and apoptosis in cancer cells. | ||||||
NSC 319726 | 71555-25-4 | sc-477736 | 10 mg | $159.00 | ||
NSC319726 is a compound that stabilizes and activates p53 by inhibiting its interaction with MDM2, promoting cell cycle arrest and apoptosis. | ||||||
PRIMA-1MET | 5291-32-7 | sc-361295 sc-361295A | 10 mg 25 mg | $150.00 $319.00 | 5 | |
PRIMA-1Met, a methylated derivative of PRIMA-1, reactivates mutant p53 by converting it to its active form, inducing apoptosis in cancer cells with mutant p53. | ||||||